Skip to content
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?
There is a great degree of renewed optimism for drug development in the ...
Read More
How to follow the 2024 BIO Investor Forum in San Francisco
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) ...
Read More
Colorado price-setting board conflicts with federal law, BIO tells court
Colorado’s efforts to impose price controls on prescription drugs are preempted by federal ...
Read More
Biotech bolsters food security amid climate challenges: I am BIO Podcast
As climate change threatens crops and shifts growing areas, maintaining food security requires ...
Read More
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large
Medicare beneficiaries will soon need to begin thinking about their coverage for 2025, ...
Read More
![Gabriella Balasa, AMR Survivor, addresses the high-level meeting on antimicrobial resistance (AMR). "This disease [cystic fibrosis] makes me highly susceptible to infections, and I'm running out of antibiotics to treat it."
The meeting was convened by the President of the General Assembly on the theme of “Investing in the present and securing our future together: accelerating multisectoral global, regional and national actions to address antimicrobial resistance”. During the meeting the “Political Declaration of the High-level Meeting on Antimicrobial Resistance” was approved. The declaration will be submitted to the General Assembly for adoption at a later date.
AMR presents a rising global threat to human, animal, and plant health, as well as food security, and the achievement of the Sustainable Development Goals. Effective antimicrobial medicines are vital to human animal and plant health; however, inappropriate use leads to the rise of resistant microorganisms, thereby undermining our ability to control and treat infections in human beings, animals, and plants. The environment also plays a critical role in the development and spread of AMR. This presents particular challenges to developing countries, as, without immediate effective actions, the potential severe economic and developmental consequences of AMR will disproportionally impact low- and middle-income countries (LMICs).](https://bio.news/wp-content/uploads/elementor/thumbs/UN71067420_20240926_LJ_AMR-14_-qvchgr3u3sky6apv7i65b4supwl6rmujz54h9z5bko.jpg "High-level Meeting on Antimicrobial Resistance (AMR)")
AMR continues to pose a global threat
September was a big month for those following antimicrobial resistance (AMR). A new ...
Read More
EDITORS' CHOICE
Exclusive: Sen. Todd Young on biosecurity, National Security Commission on Emerging Biotechnology (NSCEB)
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security. Bio.News ...
Read More
LATEST NEWS
BIO Events
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?
There is a great degree of renewed optimism for drug development in the neurodegenerative disease space. “Some of that optimism has obviously come from the ...
BIO Events
How to follow the 2024 BIO Investor Forum in San Francisco
Bio.News is heading back to San Francisco for the Biotechnology Innovation Organization (BIO) Investor Forum, one of the only independent partnering events dedicated to showcasing ...
Federal Policy
Colorado price-setting board conflicts with federal law, BIO tells court
Colorado’s efforts to impose price controls on prescription drugs are preempted by federal law, according to a legal brief by the Biotechnology Innovation Organization (BIO). ...
Agriculture
Biotech bolsters food security amid climate challenges: I am BIO Podcast
As climate change threatens crops and shifts growing areas, maintaining food security requires the kinds of improvements to plant and animal farming that biotech offers, ...
BIO's View
As Medicare open enrollment nears, ‘M3P’ and the out-of-pocket cap loom large
Medicare beneficiaries will soon need to begin thinking about their coverage for 2025, with the open enrollment period opening on Oct. 15. The next year ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
What to know about BIO’s 7 Core Strategic Priorities
With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve ...
Read More
Federal Policy
State Policy
Virginia Gov. Youngkin named BIO’s Governor of the Year
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization ...
Read More
International
Bio's View
Biotech bolsters food security amid climate challenges: I am BIO Podcast
As climate change threatens crops and shifts growing areas, maintaining food security requires the kinds of improvements to plant and ...
Read More
